Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adam S. Cheifetz, M.D.

Co-Author

This page shows the publications co-authored by Adam Cheifetz and Sarah Flier.
Connection Strength

0.644
  1. Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor. Clin Gastroenterol Hepatol. 2022 02; 20(2):465-467.e2.
    View in: PubMed
    Score: 0.228
  2. Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay. J Clin Med. 2020 Sep 02; 9(9).
    View in: PubMed
    Score: 0.223
  3. A rare case series of concomitant inflammatory bowel disease, sporadic adenomas, and serrated polyposis syndrome. J Crohns Colitis. 2014 Dec; 8(12):1735-9.
    View in: PubMed
    Score: 0.146
  4. Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. Aliment Pharmacol Ther. 2018 Apr; 47(7):913-921.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.